RED BANK, New Jersey, MELBOURNE, Australia, and BRUSSELS, Nov. 15, 2011
/CNW/ - In just 15 years, Ansell's best-selling brand sells 500M pairs
Ansell, global leader in health and safety solutions with over a century
of expertise, has today reached a historic milestone - the sale of its
500 millionth pair of HyFlex(R) gloves.
Since its creation, the HyFlex [http://www.ansell.com/corporate/en/products-brands/industrial-gbu/hyflex] (R) brand has become the number one selling industrial glove around
the world, with over half a million workers wearing it daily in a wide
variety of industries. When first introducing HyFlex(R) in 1996, Ansell
for the first time demonstrated how optimal protection does not mean
one needs to give in on comfort.
Ever since its first launch, the original HyFlex(R) concept has set a
benchmark for industry players active in this category. In 15 years,
HyFlex(R) has gained critical recognition and market share for its
winning combination of ergonomic design, comfort and superior
mechanical protection. Today, the HyFlex(R) range extends to 28
individual styles, ensuring that there is a glove that fits every
worker's job performance requirements and comfort expectations.
Magnus Nicolin, CEO of Ansell Ltd, said: "In just 15 years, Ansell [http://www.ansell.com/corporate/en/home] has sold 500 million pairs of HyFlex(R) gloves. This milestone pays
tribute to the HyFlex(R) original brand concept which is all about
delivering protection and comfort without compromise. With innovation
being the hallmark of the HyFlex(R) glove range success today, Ansell
is committed to continue to innovate and develop new ways of ensuring
that our HyFlex(R) series remains in pole position, and is the number
one choice for workers across the globe."
The HyFlex(R) brand is the most comprehensive light-duty synthetic
portfolio in the industry. Its world-leading patented Zonz(TM) Knit
Technology reduces hand fatigue by providing stress release in the
knuckle areas, setting new standards in the market.
HyFlex(R) is a registered trademark of Ansell Ltd. or one of its
SOURCE Ansell Healthcare
For further information:
Ansell Media Relations: Wouter Piepers, GCC - Ansell, Tel: +322-5287400 / +32-478335632, email@example.com; Claire Keane/Grace Milton, Edelman PR, Tel. +353-1-678-9333, Claire.firstname.lastname@example.org, email@example.com; Ansell Investor Relations: David Graham, I.R. - Ansell, Tel: +613-9270-7215 / +61-4011-40749 firstname.lastname@example.org